NuCana PLC Depreciation And Amortization Over Time

NCNA Stock  USD 1.24  0.01  0.80%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out NuCana PLC Performance and NuCana PLC Correlation.
For information on how to trade NuCana Stock refer to our How to Trade NuCana Stock guide.
  
The current year's Depreciation And Amortization is expected to grow to about 807.3 K.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NuCana PLC. If investors know NuCana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NuCana PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(14.92)
Return On Assets
(0.68)
Return On Equity
(1.81)
The market value of NuCana PLC is measured differently than its book value, which is the value of NuCana that is recorded on the company's balance sheet. Investors also form their own opinion of NuCana PLC's value that differs from its market value or its book value, called intrinsic value, which is NuCana PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NuCana PLC's market value can be influenced by many factors that don't directly affect NuCana PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NuCana PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if NuCana PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NuCana PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Depreciation And Amortization Analysis

Compare NuCana PLC and related stocks such as Effector Therapeutics, Virios Therapeutics Llc, and Zura Bio Limited Depreciation And Amortization Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
ZURA236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K228.5 K167.9 K168.8 K
ZVSA10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K9.4 K8.3 K
CDTX179 K179 K179 K179 K179 K461 K732 K667 K523 K(411 K)286 K(1.2 M)1.2 M118 K204 K
SLN1000305 K252 K297 K332 K182 K310 K433 K399 K509 K496 K427 K482 K498 K274.8 K
APLT(3 M)(3 M)(3 M)(3 M)(3 M)(3 M)(3 M)(3 M)(3 M)23 K380 K415 K441 K354 K371.7 K
CTMX655 K655 K655 K655 K783 K1.2 M1.7 M1.6 M1.9 M2.6 M5.5 M2.7 M2.4 M2.2 M2.3 M
RANI987 K987 K987 K987 K987 K987 K987 K987 K987 K987 K589 K497 K1.3 M822 K925.5 K
VINC54 K54 K54 K54 K54 K54 K54 K54 K54 K54 K5.7 K340 K939 K52 K49.4 K
TNYAMMMMMMMMMM2.5 MM6.5 M8.7 MM
CRVS175.6 K175.6 K175.6 K175.6 K175.6 K148 K594 K842 K847 K743 K632 K460 K367 K151 K143.4 K
ALXO431 K431 K431 K431 K431 K431 K431 K431 K431 K424 K202 K736 K342 K836 K544.7 K
MREO32.9 K32.9 K32.9 K32.9 K32.9 K32.9 K32.9 K36.1 K37.8 KM44 K866.5 K1.5 M1.1 M761.7 K
ABOS147 K147 K147 K147 K147 K147 K147 K147 K147 K147 K7.9 MK169 K184 K174.8 K
DAWN(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)155 K199 K531 K383 K278.5 K
INZY26 K26 K26 K26 K26 K26 K26 K26 K26 K83 K217 K1.1 M744 K833 K541.8 K

NuCana PLC and related stocks such as Effector Therapeutics, Virios Therapeutics Llc, and Zura Bio Limited Depreciation And Amortization description

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

My Equities

My Current Equities and Potential Positions

NuCana PLC
NCNA
ClassificationCancer Fighters
LocationUnited Kingdom
ExchangeNASDAQ Exchange
USD 1.24
When determining whether NuCana PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NuCana PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nucana Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nucana Plc Stock:
Check out NuCana PLC Performance and NuCana PLC Correlation.
For information on how to trade NuCana Stock refer to our How to Trade NuCana Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
NuCana PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NuCana PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NuCana PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...